USD 0.76
(-5.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 10.01 Million USD | -11.65% |
2023 | 44.46 Thousand USD | -95.67% |
2022 | 1.02 Million USD | 190.76% |
2021 | 352.86 Thousand USD | -12.2% |
2020 | 401.89 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q4 | 10.01 Million USD | 821.61% |
2024 Q3 | 1.08 Million USD | -2.59% |
2024 Q2 | 1.13 Million USD | 3.04% |
2024 Q1 | 1.14 Million USD | -90.45% |
2023 Q2 | 561.49 Thousand USD | -35.7% |
2023 Q4 | 44.46 Thousand USD | -92.65% |
2023 Q3 | 605.42 Thousand USD | 7.82% |
2023 FY | 44.46 Thousand USD | -95.67% |
2023 Q1 | 873.17 Thousand USD | -14.89% |
2022 Q3 | 1.4 Million USD | -19.45% |
2022 Q1 | 1.81 Million USD | 413.31% |
2022 FY | 1.02 Million USD | 190.76% |
2022 Q2 | 1.74 Million USD | -3.67% |
2022 Q4 | 1.02 Million USD | -27.0% |
2021 Q2 | 447.48 Thousand USD | 5.39% |
2021 Q3 | 449.16 Thousand USD | 0.37% |
2021 FY | 352.86 Thousand USD | -12.2% |
2021 Q4 | 352.86 Thousand USD | -21.44% |
2021 Q1 | 424.6 Thousand USD | 5.65% |
2020 FY | 401.89 Thousand USD | 0.0% |
2020 Q3 | - USD | -100.0% |
2020 Q4 | 401.89 Thousand USD | 0.0% |
2020 Q1 | 3020.00 USD | 0.0% |
2020 Q2 | 3132.00 USD | 3.71% |
2019 Q1 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Cosmos Health Inc. | 3.03 Million USD | -230.023% |
Safety Shot Inc | 304.9 Thousand USD | -3185.373% |
Bright Green Corporation | 201.78 Thousand USD | -4864.408% |
Embecta Corp. | 1.62 Billion USD | 99.384% |
ANI Pharmaceuticals, Inc. | 309.66 Million USD | 96.765% |
Aquestive Therapeutics, Inc. | 91.07 Million USD | 89.001% |
Collegium Pharmaceutical, Inc. | 489.96 Million USD | 97.955% |
Dynavax Technologies Corporation | 252.41 Million USD | 96.031% |
Esperion Therapeutics, Inc. | 501.54 Million USD | 98.003% |
Intra-Cellular Therapies, Inc. | 13.32 Million USD | 24.829% |
Pacira BioSciences, Inc. | 513.79 Million USD | 98.05% |
PainReform Ltd. | 30 Thousand USD | -33291.107% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1758.382% |
Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1758.382% |
SCYNEXIS, Inc. | 12.15 Million USD | 17.614% |
China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -8452.393% |
Journey Medical Corporation | 14.62 Million USD | 31.491% |
Alpha Teknova, Inc. | 13.25 Million USD | 24.403% |
Procaps Group, S.A. | 28.41 Million USD | 64.74% |
Theratechnologies Inc. | 51.26 Million USD | 80.458% |
Harrow Health, Inc. | 183.17 Million USD | 94.531% |
Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -11414.175% |
Biofrontera Inc. | 804 Thousand USD | -1145.937% |
DURECT Corporation | 2.7 Million USD | -270.738% |
Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 69.824% |
Cronos Group Inc. | 1.55 Million USD | -542.549% |
OptiNose, Inc. | 611 Thousand USD | -1539.498% |
Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 97.99% |
Kala Pharmaceuticals, Inc. | 34.19 Million USD | 70.701% |
RedHill Biopharma Ltd. | 455 Thousand USD | -2101.611% |
Organogenesis Holdings Inc. | 60.74 Million USD | 83.509% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 21.643% |
Radius Health, Inc. | 339.66 Million USD | 97.051% |
Universe Pharmaceuticals INC | - USD | -Infinity% |
ProPhase Labs, Inc. | 10.25 Million USD | 2.346% |
Phibro Animal Health Corporation | 458.28 Million USD | 97.814% |
Procaps Group S.A. | 28.41 Million USD | 64.74% |
Alvotech | 1.02 Billion USD | 99.025% |
TherapeuticsMD, Inc. | 6.53 Million USD | -53.358% |
Viatris Inc. | 16.18 Billion USD | 99.938% |
Rockwell Medical, Inc. | 8.29 Million USD | -20.793% |
Aytu BioPharma, Inc. | 10.87 Million USD | 7.904% |
SIGA Technologies, Inc. | 335.99 Thousand USD | -2881.429% |
Tilray Brands, Inc. | 287.93 Million USD | 96.521% |
Lifecore Biomedical, Inc. | 120.51 Million USD | 91.688% |
PetIQ, Inc. | 437.82 Million USD | 97.712% |
Regencell Bioscience Holdings Limited | - USD | -Infinity% |
Incannex Healthcare Limited | 210 Thousand USD | -4670.158% |
Neurocrine Biosciences, Inc. | 258.3 Million USD | 96.122% |
Alimera Sciences, Inc. | 64.48 Million USD | 84.467% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 38.51 Million USD | 73.99% |
Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -7315.357% |
Petros Pharmaceuticals, Inc. | 6.85 Million USD | -46.081% |
Clever Leaves Holdings Inc. | 720 Thousand USD | -1291.296% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -44453.158% |
Avadel Pharmaceuticals plc | 32.75 Million USD | 69.422% |
Hempacco Co., Inc. | 5.93 Million USD | -68.898% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 1.02 Billion USD | 99.025% |
Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 82.181% |
Lantheus Holdings, Inc. | 616.12 Million USD | 98.374% |
Currenc Group, Inc. | 2.5 Million USD | -299.579% |
Kamada Ltd. | 7.43 Million USD | -34.678% |
Indivior PLC | 235.66 Million USD | 95.749% |
Evoke Pharma, Inc. | 5 Million USD | -100.347% |
Flora Growth Corp. | 942 Thousand USD | -963.411% |
Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -44453.158% |
Evolus, Inc. | 120.35 Million USD | 91.677% |
HUTCHMED (China) Limited | 48.18 Million USD | 79.212% |
Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 98.3% |
Akanda Corp. | 2.49 Million USD | -301.15% |